Location History:
- Shenzhen, CN (2020 - 2022)
- Guangdong, CN (2021 - 2024)
Company Filing History:
Years Active: 2020-2025
Title: The Innovative Mind of Huanyin Li: A Trailblazer in Pharmaceutical Patents
Introduction
Huanyin Li, based in Guangdong, China, is an accomplished inventor known for his significant contributions to pharmaceutical innovation, boasting a remarkable portfolio of 14 patents. His pioneering work focuses on developing compounds that have profound implications for treating various diseases, particularly those prevalent in oncology and immunology.
Latest Patents
Among his notable innovations, Huanyin Li recently patented an aminopyrimidine compound designed to inhibit the activity of protein kinases. This invention is pivotal in the development of therapeutic strategies for cell proliferative diseases, including cancer and immune disorders. The patent outlines a novel compound, represented by a specific formula, along with a detailed method for its pharmaceutical application.
Another significant patent involves a substituted diamino heterocyclic carboxamide compound, which serves as an FLT3/AXL kinase inhibitor aimed at treating acute myelocytic leukemia. This invention includes a range of formulations, including acceptable salts and prodrugs, thus broadening its applicability in clinical settings.
Career Highlights
Huanyin Li's career has been marked by a commitment to scientific excellence and innovation. He works at Shenzhen Targetrx, Inc., a company dedicated to advancing drug discovery and development. His extensive research and inventive prowess have made significant strides in the field, contributing to the broader objective of improving patient outcomes through innovative therapies.
Collaborations
In his journey, Huanyin has collaborated with esteemed colleagues, including Yihan Wang and Xingye Ren. Together, they have fostered a dynamic research environment that encourages the exploration of groundbreaking ideas and the development of transformative solutions in healthcare.
Conclusion
Huanyin Li's work exemplifies the spirit of innovation in the pharmaceutical industry. Through his patents, he continues to pave the way for new treatments that target critical medical challenges. His contributions not only highlight advancements in drug development but also reflect the potential for future discoveries that can greatly enhance patient care and treatment efficacy.